Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Axcan Acquires Mpex Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Axcan Acquires Mpex Pharma

Axcan has entered into an agreement to acquire Mpex Pharmaceuticals, Inc. and its lead product candidate, Aeroquin, a new aerosol formulation of levofloxacin.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Axcan has entered into an agreement to acquire Mpex Pharmaceuticals, Inc. and its lead product candidate, Aeroquin, a new aerosol formulation of levofloxacin. Aeroquin is currently in Phase III development for the treatment of pulmonary infections in patients with cystic fibrosis (CF). Mpex will receive an upfront payment and a series of regulatory and success-based payments, but financial details were not disclosed. The acquisition, subject to customary closing conditions, is expected to close 2H11.

Assets not associated with Aeroquin, including financial and human resources, will be spun out of Mpex and into a newly formed company, which will remain in San Diego. Mpex personnel associated with Aeroquin development will continue to lead the clinical development program along with Axcan.

“Axcan has a long history of developing and commercializing pharmaceutical products for the cystic fibrosis community, as evidenced most recently by ZENPEP,” said Daniel Burgess, president and chief executive officer of Mpex. “We look forward to working with the dedicated team at Axcan to help bring this potentially important new treatment option to patients with CF.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters